Microfluidics-Based POCT for SARS-CoV-2 Diagnostics

A microfluidic chip is a tiny reactor that can confine and flow a specific amount of fluid into channels of tens to thousands of microns as needed and can precisely control fluid flow, pressure, temperature, etc. Point-of-care testing (POCT) requires small equipment, has short testing cycles, and co...

Full description

Saved in:
Bibliographic Details
Published in:Micromachines (Basel) 2022-08, Vol.13 (8), p.1238
Main Authors: Yin, Binfeng, Wan, Xinhua, Sohan, A. S. M. Muhtasim Fuad, Lin, Xiaodong
Format: Article
Language:English
Subjects:
Automation
Biological properties
Control equipment
Coronaviruses
COVID-19
Fluid dynamics
Fluid flow
Infectious diseases
Laboratories
Medical tests
Methods
microfluidic
Microfluidics
point of care testing
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Viral diseases
Viral infections
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A microfluidic chip is a tiny reactor that can confine and flow a specific amount of fluid into channels of tens to thousands of microns as needed and can precisely control fluid flow, pressure, temperature, etc. Point-of-care testing (POCT) requires small equipment, has short testing cycles, and controls the process, allowing single or multiple laboratory facilities to simultaneously analyze biological samples and diagnose infectious diseases. In general, rapid detection and stage assessment of viral epidemics are essential to overcome pandemic situations and diagnose promptly. Therefore, combining microfluidic devices with POCT improves detection efficiency and convenience for viral disease SARS-CoV-2. At the same time, the POCT of microfluidic chips increases user accessibility, improves accuracy and sensitivity, shortens detection time, etc., which are beneficial in detecting SARS-CoV-2. This review shares recent advances in POCT-based testing for COVID-19 and how it is better suited to help diagnose in response to the ongoing pandemic.
ISSN:2072-666X
2072-666X
DOI:10.3390/mi13081238